[The Study on Combined Screening Method for TBS and Cervical Cancer Cell’s DNA Quantitative Analysis Based on...

The traditional screening method of cervical cancer mainly involves TBS classification method and quantitative analysis method based on DNA, TBS screening method which has high diagnostic rate, but it needs experienced doctors to participate in the process with low sensitivity. Therefore, it is difficult to achieve early cervical cancer screening; cell’s DNA quantitative analysis, only stained the nucleus, achieving a quantitative and automated analysis. Even with high sensitivity, the specificity is poor. So it is extremely necessary to realize the combination of screening for TBS and cell’s DNA quantitative analysis, but the current TBS and DNA quantitative analysis combined screening method for the use of two different cell smear, time-consuming, laborious and very inconvenient, there is no screening method for cervical cancer on a combination of TBS and DNA quantitative analysis at home and abroad. This paper presents a method using TBS classification and DNA quantitative analysis on the same cell smear which was stained with Pap and Feulgen in order to solve the problem of the interference of the absorbance of DNA substance caused by multiple staining. a set of multi spectral imaging system and DNA absorbance peeling model are established based on linear multiple regression. With model solution, the real absorbance of the substance DNA was calculated, and the quantitative analysis of DNA was carried out. A pseudo color image is synthesized from 3 - band cell images with the close wavelength of RGB for TBS classification, so the organic combination of TBS and cell’s DNA quantitative analysis is realized. Experiments show that the DNA quantitative analysis model of this method is stable, with small error and high diagnostic rate due to the fact that the pseudo color images used for TBS screening were bright, clear, and clear cytoplasm. Therefore, this method is very useful in the diagnosis and screening of cervical cancer.